• Anchen is a profitable pharmaceutical company that develops and commercialized extended release and niche generic products.

    FORBES: Pharma News: United Therapeutics, Zogenix, Par Pharmaceuticals

  • When a drug loses patent protection, competition from cheaper generic products developed by competitors inevitably eats into these businesses.

    FORBES: Pfizer Q4 Earnings Preview: Pain From Patent Expirations To Continue

  • The presence of low-cost competition from generic products gives Gillette an incentive to innovate and introduce better products such as Fusion, a 6 blade razor.

    FORBES: Fat Margins Should Drive P&G Deeper Into Razor Market

  • Datamonitor, a New York-based market analysis firm, noted in a report, published March 2001, of an industry shift towards "high-barrier-to-entry generic products, " or specialty generic pharmaceuticals.

    FORBES: Super Generic Drug Companies

  • The combined company will produce more than 300 generic products, and Teva says its pipeline of generic drugs will be considerably bigger than any of its rivals.

    FORBES

  • It won't be easy: Mail-order services, new generic products and shrinking reimbursements from Medicare and Medicaid have hampered retail-pharmacy sales of prescription drugs, which account for 63% of Rite Aid's top line.

    FORBES: Rite Aid Gets Some Relief

  • Mr Vasella claims that big buyers, such as Wal-Mart in America and health-care providers in emerging markets, want to be able to buy a full range of patented and generic products from one supplier.

    ECONOMIST: The best medicine? | The

  • Beginning calendar year 2014, this will increasingly include generic pharmaceutical products that Walgreen has so far self-distributed.

    FORBES: Quick Take

  • Already, Pfizer's sales are flat because of generic competition for products like antibiotic Zithromax and nerve-pain drug Neurontin.

    FORBES: Magazine Article

  • Sanofi-Aventis has said that it will move further into the generic business, and GSK has licensed some products with expiring patents to generic companies for a share of the profits.

    ECONOMIST: The best medicine? | The

  • Bernstein analyst Ronny Gal, given the proportion of pharmaceutical revenues now generated by biologic products traditional generic drug manufacturers have little choice but to pursue biosimilar development.

    FORBES: Gamekeeper or Poacher? - Big Pharma's Stance on Biosimilars

  • People often buy brand-name products over their generic alternatives for fairly obvious reasons.

    FORBES: Why Generic Products Can Make You Feel Bad About Yourself

  • There are four possible divisions that Pfizer could spin off: baby formula, over-the-counter products, veterinary medicine, and established products, which includes generic drugs.

    FORBES: Will Pfizer Break Up?

  • The biggest controversy is whether Pfizer will spin off its established products unit, which sells generic drugs and branded medicines like Norvasc and Zoloft that have lost patent protection.

    FORBES: Why Pfizer Will Break Up

  • In the U.S. generic companies can sell off-patent products immediately, but they have to compensate the company that originally registered the chemical with the Environmental Protection Agency--Monsanto in this case--for the data showing the product's safety and efficacy.

    FORBES: Pesticide Prince

  • EU. They want protection from those generic-drug firms tempted to copy their products, which may lack European patents.

    ECONOMIST: Rare diseases: Safety in numbers | The

  • This year, Mylan expects to launch worldwide more than 500 new products, including a line of generic oral contraceptives.

    FORBES: How Now Dow Jones? With Almost Everyone Turning Negative On The Market, Is It Time To Buy?

  • Patent rules can be bent in a variety of ways to delay generic drugmakers from bringing previously patent-protected products to market.

    ECONOMIST: The best medicine? | The

  • Generic drug companies are also developing their own proprietary products to grab a little piece of the lucrative branded market.

    FORBES: Super Generic Drug Companies

  • Ranbaxy was on the way to becoming one of the world's leading makers of generic drugs, just as the boom in such products was taking off in the mid-1990s.

    ECONOMIST: A new breed of multinational company has emerged

  • Akorn is a niche generic pharmaceutical company that develops, manufactures and markets pharmaceutical products in the areas of ophthalmology, antidotes and anti-infectives in addition to controlled substances for pain management and anesthesia.

    FORBES: Akorn Stock Has Healthy Upside

  • The companies said the collaboration reflects the shared belief that the development and commercialization of biosimilar products will not follow a pure brand or generic model and will require significant expertise, infrastructure and investment to ensure safe, reliably supplied therapies.

    FORBES: Cancer Drug Partnerships: Immunogen to Collaborate with Lilly, Amgen Partners with Watson

  • Second of all, it teaches girls and women that products targeted at them are inherently different from the generic or normal.

    FORBES: How Hollywood Markets to Women by Reinforcing Gender Stereotypes

  • Pfizer, the world's largest drug maker by sales, has been shedding businesses outside its core medicine franchise to focus on developing prescription medicines to replace aging products such as cholesterol drug Lipitor, which now faces generic competition.

    WSJ: Zoetis Jumps 21% in Debut

  • Converging technologies is a generic term for technologies which interact with one another in the development of new products and services.

    UNESCO: World Water Assessment Programme (WWAP)

  • Some big drug firms are also suspected of colluding with generic rivals ie, paying them to delay bringing non-branded products to market.

    ECONOMIST: The best medicine? | The

  • Clark added the company's Clinical and Medical Products sector will be a key growth driver, and expects to benefit from new generic pharmaceutical launches and improvements in operational performance.

    FORBES: Magazine Article

  • The news is bad for Eli Lilly, too, as it is already struggling with slow sales on newer products and a wave of patent experations that has been worsened by recent losses against generic drug makers in court.

    FORBES: FDA Disaster For Diabetes Drug

  • AmerisourceBergen is a pharmacy services provider and will distribute branded pharmaceutical products that Walgreen has historically distributed, and it will help Walgreen source and distribute generic drugs internationally potentially bringing both growth and better purchasing power with drug manufacturers.

    FORBES: Quick Take

  • Justices ruled in 2011 that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the brand-name equivalents of the medicines as required by federal law.

    NPR: Court: Can Generic Drug Maker Be Sued Over Design?

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定